Horn Kinney
Chief Business Officer
Exercise
Calculated transaction value
$0
1,092 shares @ $0
Traded
Jul 7, 2026
Filed
Jul 9, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Immunome
IMNM
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
59 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Horn Kinney Chief Business Officer | Jul 9, 2026 2-day lag | Exercise Jul 7, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Barchas Isaac Director | Jul 7, 2026 Same-day filing | Sale Jul 7, 2026 | $409.13K Filed shares x price | SEC Form 4 View filing | |
| Barchas Isaac Director | Jul 7, 2026 1-day lag | Sale Jul 6, 2026 | $2M Filed shares x price | SEC Form 4 View filing | |
| Lechleider Robert Chief Medical Officer | Jul 7, 2026 5-day lag | Exercise Jul 2, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lechleider Robert Chief Medical Officer | Jul 7, 2026 5-day lag | Sale Jul 2, 2026 | $376.73K Filed shares x price | SEC Form 4 View filing | |
| Lechleider Robert Chief Medical Officer | Jul 7, 2026 5-day lag | Sale Jul 2, 2026 | $498.57K Filed shares x price | SEC Form 4 View filing | |
| Lechleider Robert Chief Medical Officer | Jul 7, 2026 5-day lag | Sale Jul 2, 2026 | $369.03K Filed shares x price | SEC Form 4 View filing | |
| Lechleider Robert Chief Medical Officer | Jul 7, 2026 5-day lag | Exercise Jul 2, 2026 | $480.15K Filed shares x price | SEC Form 4 View filing | |
| Barchas Isaac Director | Jul 2, 2026 Same-day filing | Sale Jul 2, 2026 | $567.74K Filed shares x price | SEC Form 4 View filing | |
| Barchas Isaac Director | Jul 2, 2026 Same-day filing | Sale Jul 2, 2026 | $1.69M Filed shares x price | SEC Form 4 View filing | |
| Barchas Isaac Director | Jul 2, 2026 2-day lag | Sale Jun 30, 2026 | $2.13M Filed shares x price | SEC Form 4 View filing | |
| Lechleider Robert Chief Medical Officer | Jun 29, 2026 4-day lag | Sale Jun 25, 2026 | $297.92K Filed shares x price | SEC Form 4 View filing | |
| Lechleider Robert Chief Medical Officer | Jun 29, 2026 4-day lag | Sale Jun 25, 2026 | $793.74K Filed shares x price | SEC Form 4 View filing | |
| Lechleider Robert Chief Medical Officer | Jun 29, 2026 4-day lag | Exercise Jun 25, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lechleider Robert Chief Medical Officer | Jun 29, 2026 4-day lag | Exercise Jun 25, 2026 | $480.15K Filed shares x price | SEC Form 4 View filing | |
| Rosett Max Chief Financial Officer | Jun 17, 2026 2-day lag | Sale Jun 15, 2026 | $1.09M Filed shares x price | SEC Form 4 View filing | |
| Rosett Max Chief Financial Officer | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Rosett Max Chief Financial Officer | Jun 17, 2026 2-day lag | Exercise Jun 15, 2026 | $63K Filed shares x price | SEC Form 4 View filing | |
| Barchas Isaac Director | Jun 12, 2026 2-day lag | Award Jun 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Boylan James P Director | Jun 12, 2026 2-day lag | Award Jun 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Jun 12, 2026 2-day lag | Award Jun 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Wagenheim Philip Director | Jun 12, 2026 2-day lag | Award Jun 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Schafer Carol Director | Jun 12, 2026 2-day lag | Award Jun 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Swain Sandra M Director | Jun 12, 2026 2-day lag | Award Jun 10, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Jun 9, 2026 4-day lag | Sale Jun 5, 2026 | $194.1K Filed shares x price | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Jun 9, 2026 4-day lag | Sale Jun 5, 2026 | $9.72K Filed shares x price | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Jun 9, 2026 4-day lag | Buy Jun 5, 2026 | $19.27K Filed shares x price | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Jun 9, 2026 4-day lag | Buy Jun 5, 2026 | $68.11K Filed shares x price | SEC Form 4 View filing | |
| Bienaime Jean Jacques Director | Jun 9, 2026 4-day lag | Buy Jun 5, 2026 | $116.88K Filed shares x price | SEC Form 4 View filing |
Barchas Isaac
Director
Sale
Calculated transaction value
$409.13K
16,906 shares @ $24.2
Traded
Jul 7, 2026
Filed
Jul 7, 2026
Barchas Isaac
Director
Sale
Calculated transaction value
$2M
83,094 shares @ $24.11
Traded
Jul 6, 2026
Filed
Jul 7, 2026
Lechleider Robert
Chief Medical Officer
Exercise
Calculated transaction value
$0
55,000 shares @ $0
Traded
Jul 2, 2026
Filed
Jul 7, 2026
Lechleider Robert
Chief Medical Officer
Sale
Calculated transaction value
$376.73K
16,072 shares @ $23.44
Traded
Jul 2, 2026
Filed
Jul 7, 2026
Lechleider Robert
Chief Medical Officer
Sale
Calculated transaction value
$498.57K
22,714 shares @ $21.95
Traded
Jul 2, 2026
Filed
Jul 7, 2026
Lechleider Robert
Chief Medical Officer
Sale
Calculated transaction value
$369.03K
16,214 shares @ $22.76
Traded
Jul 2, 2026
Filed
Jul 7, 2026
Lechleider Robert
Chief Medical Officer
Exercise
Calculated transaction value
$480.15K
55,000 shares @ $8.73
Traded
Jul 2, 2026
Filed
Jul 7, 2026
Barchas Isaac
Director
Sale
Calculated transaction value
$567.74K
24,335 shares @ $23.33
Traded
Jul 2, 2026
Filed
Jul 2, 2026
Barchas Isaac
Director
Sale
Calculated transaction value
$1.69M
75,665 shares @ $22.35
Traded
Jul 2, 2026
Filed
Jul 2, 2026
Barchas Isaac
Director
Sale
Calculated transaction value
$2.13M
101,050 shares @ $21.12
Traded
Jun 30, 2026
Filed
Jul 2, 2026
Lechleider Robert
Chief Medical Officer
Sale
Calculated transaction value
$297.92K
14,420 shares @ $20.66
Traded
Jun 25, 2026
Filed
Jun 29, 2026
Lechleider Robert
Chief Medical Officer
Sale
Calculated transaction value
$793.74K
40,580 shares @ $19.56
Traded
Jun 25, 2026
Filed
Jun 29, 2026
Lechleider Robert
Chief Medical Officer
Exercise
Calculated transaction value
$0
55,000 shares @ $0
Traded
Jun 25, 2026
Filed
Jun 29, 2026
Lechleider Robert
Chief Medical Officer
Exercise
Calculated transaction value
$480.15K
55,000 shares @ $8.73
Traded
Jun 25, 2026
Filed
Jun 29, 2026
Rosett Max
Chief Financial Officer
Sale
Calculated transaction value
$1.09M
60,000 shares @ $18.23
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Rosett Max
Chief Financial Officer
Exercise
Calculated transaction value
$0
60,000 shares @ $0
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Rosett Max
Chief Financial Officer
Exercise
Calculated transaction value
$63K
60,000 shares @ $1.05
Traded
Jun 15, 2026
Filed
Jun 17, 2026
Barchas Isaac
Director
Award
Calculated transaction value
$0
9,897 shares @ $0
Traded
Jun 10, 2026
Filed
Jun 12, 2026
Boylan James P
Director
Award
Calculated transaction value
$0
9,897 shares @ $0
Traded
Jun 10, 2026
Filed
Jun 12, 2026
Bienaime Jean Jacques
Director
Award
Calculated transaction value
$0
9,897 shares @ $0
Traded
Jun 10, 2026
Filed
Jun 12, 2026
Wagenheim Philip
Director
Award
Calculated transaction value
$0
9,897 shares @ $0
Traded
Jun 10, 2026
Filed
Jun 12, 2026
Schafer Carol
Director
Award
Calculated transaction value
$0
9,897 shares @ $0
Traded
Jun 10, 2026
Filed
Jun 12, 2026
Swain Sandra M
Director
Award
Calculated transaction value
$0
9,897 shares @ $0
Traded
Jun 10, 2026
Filed
Jun 12, 2026
Bienaime Jean Jacques
Director
Sale
Calculated transaction value
$194.1K
10,000 shares @ $19.41
Traded
Jun 5, 2026
Filed
Jun 9, 2026
Bienaime Jean Jacques
Director
Sale
Calculated transaction value
$9.72K
500 shares @ $19.44
Traded
Jun 5, 2026
Filed
Jun 9, 2026
Bienaime Jean Jacques
Director
Buy
Calculated transaction value
$19.27K
1,000 shares @ $19.27
Traded
Jun 5, 2026
Filed
Jun 9, 2026
Bienaime Jean Jacques
Director
Buy
Calculated transaction value
$68.11K
3,500 shares @ $19.46
Traded
Jun 5, 2026
Filed
Jun 9, 2026
Bienaime Jean Jacques
Director
Buy
Calculated transaction value
$116.88K
6,000 shares @ $19.48
Traded
Jun 5, 2026
Filed
Jun 9, 2026